The Association of CYP2E1 Polymorphism and Environmental Factor in Nasopharyngeal Carcinoma Patients

Farhat Farhat; Elvita Rahmi Daulay; Jessy Chrestella; Raudah Putri Syari

doi:10.3889/oamjms.2020.4639

Authors

Farhat Farhat Department of Otorhinolaryngology Head and Neck Surgery, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Elvita Rahmi Daulay Department of Radiology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Jessy Chrestella Department of Anatomic Pathology, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia
Raudah Putri Syari Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia

DOI:

https://doi.org/10.3889/oamjms.2020.4639

Keywords:

CYP2E1 enzyme, nasopharyngeal carcinoma, polymorphism, risk factor

Abstract

INTRODUCTION: Polymorphism of CYP2E1 induces nasopharyngeal carcinoma (NPC) by activating pro-carcinogens including nitrosamine. Environmental factor such as salted fish, preserved food, tobacco, and alcohol consumption which contains nitrosamine, join with CYP2E1 polymorphism leads to an increase of susceptibility for NPC.

OBJECTIVE: The aims of this study were to identify CYP2E1 polymorphism and the association with other risk factors to NPC in NPC patients.

METHODS: This study was analytic research with the case–control design. The samples were taken based on non-probability consecutive sampling method. The identification of CYP2E1 polymorphism was done by the PCR-RFLP method. The association of its variable to NPC was analyzed with the Chi-square test and between polymorphism of CYP2E1 with other risk factors was analyzed with stratified analysis.

RESULT: We found that there was no significant association of CYP2E1 polymorphism with NPC. However, the joint effect of CYP2E1 polymorphism with smoking was significant in NPC patients. The risk for NPC in the combination of those two was 4.0-fold.

CONCLUSION: The study showed the capability of genetics and environment in the development of NPC. Further study can be done to find evidence of genetics and environmental influence in the prevention and treatment of NPC.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Zhao Y, Wang Y, Wu X, Wang J, Zhang L, Jia Y, et al. Quantitative assessment of the association between glutathione S-transferase M1 polymorphism and the risk of developing nasopharyngeal cancer. Oncol Lett. 2016;11(1):373-8. https:// doi.org/10.3892/ol.2015.3848 PMid:26870220

Li L, Gu M, You B, Shi S, Shan Y, Bao L, et al. Long non-coding RNA ROR promotes proliferation, migration, and chemoresistance of nasopharyngeal carcinoma. Cancer science. 2016;107(9):1215- 22. https://doi.org/10.1111/cas.12989 PMid:27311700

Chen X, Li P, Yang Z, Mo WN. Expression of fragile histidine triad (FHIT) and WW-domain oxidoreductase gene (WWOX) in nasopharyngeal carcinoma. Asian Pac J Cancer Prevent. 2013;14(1):165-71. https://doi.org/10.7314/apjcp.2013.14.1.165 PMid:23534718

Qin H, Yao Y. From family study to population study: A history of genetic mapping for nasopharyngeal carcinoma (NPC). In: Applied Computational Genomics. Berlin: Springer; 2018. p. 81-106. https://doi.org/10.1007/978-981-13-1071-3_7

Mahdavifar N, Towhidi F, Makhsosi BR, Pakzad R, Moini A, Ahmadi A, et al. Incidence and mortality of nasopharynx cancer and its relationship with human development index in the world in 2012. World J Oncol. 2016;7(5-6):109-18. https://doi. org/10.14740/wjon980w PMid:28983375

Farhat F, Daulay ER, Chrestella J, Asnir RA, Yudhistira A, Susilo RR. Correlation of P38 mitogen-activated protein kinase expression to clinical stage in nasopharyngeal carcinoma. Open Access Maced J Med Sci. 2018;6(11):1982-5. https://doi. org/10.3889/oamjms.2018.355 PMid:30559847

Wei KR, Zheng RS, Zhang SW, Liang ZH, Ou ZX, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China in 2010. Chinese journal of cancer. 2014;33(8):381.

Adham M, Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S, et al. Nasopharyngeal carcinoma in Indonesia: Epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer. 2012;31(4):185. https://doi. org/10.5732/cjc.011.10328

Lung ML, Cheung AKL, Ko JMY, Lung HL, Cheng Y, Dai W. The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma. Chinese journal of cancer. 2014;33(11):556. https://doi.org/10.5732/cjc.014.10170

Zeng MS, Zeng YX. Pathogenesis and etiology of nasopharyngeal carcinoma. Nasopharyngeal Cancer: Springer; 2010. p. 9-25.

Dai W, Zheng H, Cheung AK, Lung ML. Genetic and epigenetic landscape of nasopharyngeal carcinoma. Chin Clin Oncol. 2016;5(2):16. PMid:27121876

Ghania D, Katia B, Yahia K, Monia A, Douik H, Fethi G, et al. Association between genetic polymorphisms of human cytochrome cyp2e1 and risk of nasopharyngeal carcinoma in algeria population. Int J Pharm Pharm Sci. 2018;10:76. https:// doi.org/10.22159/ijpps.2018v10i4.23389

Lo KW, Chung GT, To KF. Acquired genetic and epigenetic alterations in nasopharyngeal carcinoma. In: Nasopharyngeal Carcinoma. Berlin: Springer; 2013. p. 61-81.

Nosheen M, Ishrat M, Malik F, Baig R, Kayani M. Association of GSTM1 and GSTT1 gene deletions with risk of head and neck cancer in Pakistan: A case control study. Asian Pac J Cancer Prev. 2010;11(4):881-5. PMid:21133595

Park JE, Seo JE, Lee JY, Kwon H. Distribution of seven N-nitrosamines in food. Toxicol Res. 2015;31(3):279-88. https:// doi.org/10.5487/tr.2015.31.3.279 PMid:26483887

Fukushima S, Gi M, Kakehashi A, Wanibuchi H. Qualitative and quantitative assessments on low-dose carcinogenicity of genotoxic hepatocarcinogens: Dose response for key events in rat hepatocarcinogenesis. In: Thresholds of Genotoxic Carcinogens. Amsterdam, Netherlands: Elsevier; 2016. p. 1-17. https://doi.org/10.1016/b978-0-12-801663-3.00001-7

Smith MT, Guyton KZ, Gibbons CF, Fritz JM, Portier CJ, Rusyn I, et al. Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis. Environ Health Perspect. 2015;124(6):713-21. https://doi.org/10.1289/ ehp.1509912 PMid:26600562

Wei KR, Zheng RS, Zhang SW, Liang ZH, Li ZM, Chen WQ. Nasopharyngeal carcinoma incidence and mortality in China, 2013. Chin J Cancer. 2017;36(1):90. https://doi.org/10.1186/ s40880-017-0257-9 PMid:25096544

Ruuskanen M, Irjala H, Minn H, Vahlberg T, Randen-Brady R, Hagström J, et al. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland. Head Neck. 2019;41(2):349-57. https://doi.org/10.1002/hed.25450 PMid:30549170

Feng BJ. Descriptive, environmental and genetic epidemiology of nasopharyngeal carcinoma. In: Nasopharyngeal Carcinoma. Berlin: Springer; 2013. p. 23-41. https://doi. org/10.1007/978-1-4614-5947-7_3

Xiao G, Cao Y, Qiu X, Wang W, Wang Y. Influence of gender and age on the survival of patients with nasopharyngeal carcinoma. BMC Cancer. 2013;13(1):226. https://doi. org/10.1186/1471-2407-13-226

Xie SH, Yu IT, Tse LA, Mang OW, Yue L. Sex difference in the incidence of nasopharyngeal carcinoma in Hong Kong 1983- 2008: Suggestion of a potential protective role of oestrogen. Eur J Cancer. 2013;49(1):150-5. https://doi.org/10.1016/j. ejca.2012.07.004 PMid:22892061

Umar B, Ahmed R. Nasopharyngeal carcinoma, an analysis of histological subtypes and their association with EBV, a study of 100 cases of Pakistani population. Asian J Med Sci. 2014;5(4):16-20. https://doi.org/10.3126/ajms.v5i4.9592

Chua ML, Wee JT, Hui EP, Chan AT. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012-24. https://doi.org/10.1016/ s0140-6736(15)00055-0 PMid:26321262

Colaco RJ, Betts G, Donne A, Swindell R, Yap BK, Sykes AJ, et al. Nasopharyngeal carcinoma a retrospective review of demographics, treatment and patient outcome in a single centre. Clin Oncol. 2013;25(3):171-7. https://doi.org/10.1016/j. clon.2012.10.006 PMid:23337060

Kamran SC, Riaz N, Lee N. Nasopharyngeal carcinoma. Surg Oncol Clin. 2015;24(3):547-61. PMid:25979399

Tang LL, Chen WQ, Xue WQ, He YQ, Zheng RS, Zeng YX, et al. Global trends in incidence and mortality of nasopharyngeal carcinoma. Cancer Lett. 2016;374(1):22-30. https://doi. org/10.1016/j.canlet.2016.01.040 PMid:26828135

Pan J, Tang T, Xu L, Lu JJ, Lin S, Qiu S, et al. Prognostic significance of expression of cyclooxygenase-2, vascular endothelial growth factor, and epidermal growth factor receptor in nasopharyngeal carcinoma. Head Neck. 2013;35(9):1238-47. https://doi.org/10.1002/hed.23116 PMid:22972415

Ji X, Zhang W, Xie C, Wang B, Zhang G, Zhou F. Nasopharyngeal carcinoma risk by histologic type in central China: Impact of smoking, alcohol and family history. Int J Cancer. 2011;129(3):724-32. https://doi.org/10.1002/ijc.25696 PMid:20878958

Yong SK, Ha TC, Yeo MC, Gaborieau V, McKay JD, Wee J. Associations of lifestyle and diet with the risk of nasopharyngeal carcinoma in Singapore: A case-control study. Chin J Cancer. 2017;36(1):3. https://doi.org/10.1186/s40880-016-0174-3 PMid:28063457

Yalcin E, de la Monte S. Tobacco nitrosamines as culprits in disease: Mechanisms reviewed. J Physiol Biochem. 2016;72(1):107-20. https://doi.org/10.1007/s13105-016-0465-9 PMid:26767836

Ekburanawat W, Ekpanyaskul C, Brennan P, Kanka C, Tepsuwan K, Temiyastith S, et al. Evaluation of non-viral risk factors for nasopharyngeal carcinoma in Thailand: Results from a case-control study. Asian Pac J Cancer Prev. 2010;11(4):929-32. PMid:21133603

Xue WQ, Qin HD, Ruan HL, Shugart YY, Jia WH. Quantitative association of tobacco smoking with the risk of nasopharyngeal carcinoma: A comprehensive meta-analysis of studies conducted between 1979 and 2011. Am J Epidemiol. 2013;178(3):325-38. https://doi.org/10.1093/aje/kws479 PMid:23785114

Gao J, Wang GJ, Wang Z, Gao N, Li J, Zhang YF, et al. High CYP2E1 activity correlates with hepatofibrogenesis induced by nitrosamines. Oncotarget. 2017;8(68):112199-210. https://doi. org/10.18632/oncotarget.22937 PMid:29348818

García-Suástegui W, Ramos-Chávez L, Rubio-Osornio M, Calvillo-Velasco M, Atzin-Méndez J, Guevara J, et al. The Role of CYP2E1 in the Drug Metabolism or Bioactivation in the Brain. Oxid Med Cell Longev. 2017;2017:4680732. https://doi. org/10.1155/2017/4680732 PMid:28163821

Kao JH, Amarapurkar D, Fan JG. NAFLD in Chinese and South Asian People. United States: Non-Alcoholic Fatty Liver; 2013. p. 206. https://doi.org/10.1002/9781118556153.ch18

Jiménez-Garza O, Baccarelli AA, Byun HM, Márquez-Gamiño S, Barrón-Vivanco BS, Albores A. CYP2E1 epigenetic regulation in chronic, low-level toluene exposure: Relationship with oxidative stress and smoking habit. Toxicol Appl Pharmacol. 2015;286(3):207-15. https://doi.org/10.1016/j.taap.2015.04.016 PMid:25963742

Zanger UM, Schwab M. Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation. Pharmacol Ther. 2013;138(1):103-41. https://doi.org/10.1016/j. pharmthera.2012.12.007 PMid:23333322

Klaunig JE, Kamendulis LM, Hocevar BA. Oxidative stress and oxidative damage in carcinogenesis. Toxicol Pathol. 2010;38(1):96-109. https://doi.org/10.1177/0192623309356453 PMid:20019356

Takamori J, Santos M, Peterle G, Rossi L, Curioni O, Gazito D, et al. Alcohol metabolizing gene polymorphisms and their relationship with oral cancer risk and clinicopathological. Genet Mol Res 2017;16:gmr16039829. https://doi.org/10.4238/ gmr16039829

Karakoc MD, Kortunay S, Kara CO, Topuz B. CYP2E1 and ALDH2 gene polymorphisms in squamous cell head and neck Cancer in the Turkish population. Int J Hematol Oncol. 2019;29(2):61-9.

Jia WH, Pan QH, Qin HD, Xu YF, Shen GP, Chen L, et al. A case control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese. Carcinogenesis. 2009;30(12):2031-6. https://doi.org/10.1093/carcin/bgp239 PMid:19805575

Yao K, Qin H, Gong L, Zhang R, Li L. CYP2E1 polymorphisms and nasopharyngeal carcinoma risk: A meta-analysis. Eur Arch Otorhinolaryngol. 2017;274(1):253-9. https://doi.org/10.1007/ s00405-016-4236-6 PMid:27491320